CX3CR1 and amyotrophic lateral sclerosis: Surprisingly, in contrast to DAM in AD mouse models, DAM in ALS models significantly up-regulated inhibitory checkpoints (Cx3cr1 and P2ry12), as validated by ISH (Fig. 6C and D).